Search results for " facility" in Articles / App Notes
Article
Making the Move to Continuous Chromatography
Making the Move to Continuous Chromatography
Early adopters are benefiting from lower costs and increased productivity.
By Cynthia A. Challener
Tashatuvango/Shu…
Article
Biopharmaceutical Market in Asia: Q&A with Günter Jagschies, Strategic Customer Relations Leader, Cytiva
Specific topics will be the review of health challenges in Asia and future approaches to address them, creative technology solutions, facility and regulatory aspects, as well as vaccines and plasma de…
Article
FDA Framework Spurs Advanced Therapies
Lonza will be opening a new and largest-of-its-kind dedicated cell- and gene-manufacturing facility in Houston, TX, early in 2018, in direct response to these concerns.
In addition to manufactu…
Article
Reliability Rooms and the Move to Proactive Supply Chain Management
Teams at each facility track goals on a weekly basis to discern new and emerging issues. This approach allows the team to get ahead of and mitigate any supply chain problems in the making.
Once…
Article
Manufacturing Standards Key to Advancing Cellular and Gene Therapies
…r removing blood T-cells from the patient, cryopreserving them for transport to a company processing facility, and shipping transduced T-cells back to the clinic for re-injection into the patient.
…
Article
Will My Buffers Work When Using an Inline Conditioning System?
The system can be used off-line as a standalone central buffer preparation station to feed different processes in the facility or in-line connected to a chromatography column using a built-in chromato…
Article
The New World of Biopharmaceutical Manufacturing
Industry experts discuss the single-use revolution and changes to upstream and downstream processing equipment.
By Jennifer Markarian
…
Article
From Darwin to Recombinant Fc Multimers
LFB has made a big commitment to expand its manufacturing capacity with an investment of €300M, and initiated a new facility project in Arras, north of France in 2016, with an objective to fractionate…
Article
Unifying Continuous Biomanufacturing Operations
…safer processes), lower risk associated with changing scale, lower capital and operating costs for a facility, and maximization of column capacity/resin use. Some of these benefits could fluctuate ba…
Article
Ensuring the Biological Integrity of Raw Materials
By Catherine Shaffer
Contamination with microbes, mycoplasma, viruses, and other adventitious agents can be a significant problem in biopharmaceutical manufacturing. Although contamination can o…